Paul Mampilly is recently speaking out about the fact that Amazon’s interest in healthcare stocks could ruin its investors. He has advised the readers of his newsletter to listen to David Larsen who is saying the same thing he is about Amazon entering the stock market by investing in healthcare companies. Mampilly has explained that many of his followers are invested in the stocks that Amazon is planning on investing in, too, and the problem is that Amazon will disrupt them, completely, once they set their sites on them.
According to Paul Mampilly, and many other experts, Amazon is looking to invest in prescription drug companies. The problem with this is that once Amazon sets its sites on a company, they are beholden to become more transparent about their lesser-known complex chain of rebates and costs, and while middlemen will profit during this commotion, the stock itself will drop rapidly. He has pointed out that the only benefit of Amazon getting involved is that prescription medications will be more affordable for the consumer. In the meantime, everyone else, including the pharmacies, will lose money in the process. The profit margins of companies like Walgreens, CVS, and Express Scripts will also be affected greatly and might have a difficult time recovering.
Paul Mampilly is an American investor who won the well-known Templeton Foundation investment competition. He studied at City University of New York-Hunter College and New York University Polytechnic School of Engineering. He earned an MBA in Finance while attending Fordham Gabelli School of Business. His career began with him working on Wall Street for Bankers Trust as an assistant portfolio manager. After this, he went on to work with ING and Deutsche Bank managing million-dollar accounts. His talents got him noticed, because in 2006, He was recruited to manage the hedge fund of the multi-billion dollar firm, Kinetics Asset.
After working for so many years on Wall Street, Paul Mampilly grew weary of making the rich richer and desired to start helping the common person. In 2016, he teamed up with Banyon Hill Publishing and is now their senior editor. His mission there is to help regular, working Americans to build wealth through technology, growth investing, and small-cap stocks. His advice has been monumental to many people, and his newsletters, Profits Unlimited and Extreme Fortunes, have given people the tools and information they need to become successful in the investing world, themselves.
About Paul Mampilly: www.linkedin.com/in/paulmampilly